SCHEMBL28648458

SCHEMBL28648458

CCC(=O)Cc1ccc(NC2CC(F)(F)C2)c(NC2CC(F)(F)C2)n1

nearest known ligand 0.39

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.39
MBOAT4 Q96T53 3/20 0.38
GRM4 Q14833 1/20 0.34
JAK2 O60674 1/20 0.32
GPR6 P46095 1/20 0.31
PIM1 P11309 1/20 0.31
PIM2 Q9P1W9 1/20 0.31
NLRP3 Q96P20 1/20 0.31
IDH1 O75874 2/20 0.31
IRAK1 P51617 1/20 0.30
IRAK4 Q9NWZ3 1/20 0.30
BCDIN3D Q7Z5W3 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30873917 1.00 TRPA1 (0.39) TRPA1MBOAT4GRM4JAK2GPR6
SCHEMBL30873882 0.87 MBOAT4 (0.41) TRPA1MBOAT4GRM4JAK2IDH1
SCHEMBL28926930 0.87 MBOAT4 (0.41) TRPA1MBOAT4GRM4JAK2IDH1
SCHEMBL22428683 0.76 GRM4 (0.39) TRPA1MBOAT4GRM4JAK2GPR6
SCHEMBL22411285 0.73 MBOAT4 (0.34) TRPA1MBOAT4GRM4JAK2IDH1
SCHEMBL17115670 0.66 IDH1 (0.37) TRPA1GRM4IDH1
SCHEMBL22428682 0.63 GRM4 (0.38) TRPA1MBOAT4GRM4JAK2IDH1
SCHEMBL22411339 0.60 MBOAT4 (0.37) TRPA1MBOAT4GRM4JAK2IDH1
SCHEMBL31612111 0.59 KMT2A (0.42) TRPA1GRM4
SCHEMBL26618136 0.59 GRM4 (0.39) TRPA1GRM4IDH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118290350-A Heteroaryl and bisheteroaryl derivatives for the treatment of iron death-related disorders 协同医药发展有限公司 2024-07-05 CN disclosed
CN-113631535-B Heteroaryl and bisheteroaryl derivatives for the treatment of iron death-related disorders 协同医药发展有限公司 2024-04-12 CN disclosed
CN-113631535-A Heteroaryl and bis-heterocyclic aryl derivatives for the treatment of disorders associated with iron death 协同医药发展有限公司 2021-11-09 CN disclosed